Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

The relevance of blood-based assays to monitor minimal residual disease (MRD) in non-metastatic prostate cancer (PCa) remains unclear. Proving that clinically relevant circulating tumor cells (CTCs) can be detected with available technologies could address this. This study aimed to improve CTC detec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Kuske, Andra, Gorges, Tobias M., Tennstedt, Pierre, Tiebel, Anne-Kathrin, Pompe, Raisa, Preißer, Felix, Prues, Sandra, Mazel, Martine, Markou, Athina, Lianidou, Evi, Peine, Sven, Alix-Panabières, Catherine, Riethdorf, Sabine, Beyer, Burkhard, Schlomm, Thorsten, Pantel, Klaus
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5175156/
https://ncbi.nlm.nih.gov/pubmed/28000772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep39736
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares